NIH-funded study focuses on next-day effects of heavy drinking on young adults

Nausea, headaches and difficulty concentrating are just a few of the hangover symptoms that can besiege young adults who drink alcohol to excess.

BridgeBio’s $250M offering; ViiV’s PhI data for ultra-long-acting HIV treatment

Plus, news about Viking Therapeutics, Arcutis Biotherapeutics, Akari and Peak Bio: BridgeBio’s stock sale: The company announced plans to raise $250 million the same day

March 6, 2024

Public health concerns as highly pathogenic avian influenza A(H5N1) virus found in cat in France

Study describes the identification of a highly pathogenic avian influenza A virus in a domestic cat.

June 28, 2023

RioDerm-004 by Rion for Fistula: Likelihood of Approval

RioDerm-004 is under clinical development by Rion and currently in Phase I for Fistula.

February 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.